
After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
The Central Vista Construction case was heard in the Supreme Court. Advocate Siddharth Luthra, ap
After Twitter, there is now news of massive layoffs in the social media site Facebook's parent co
While addressing the Congress, US President Donald Trump placed India, China, South Korea and man
The investigation into the rape and murder of a female doctor in West Bengal has intensified. In
Rising heat can scorch the country's economy, apart from life, a heatwave can also take away jobs
India can no longer ignore issues like global warming. On the one hand, where there is scorching
Bomb Threat In India: Schools and airports in many states of the country are receiving bomb
Vivek Agnihotri's film 'The Kashmir Files' is growing at a great pace at the box office. The film
On the special occasion of Independence Day, actor Akshay Kumar has good news for his fans. Aksha
The case regarding the upcoming film "The Kerala Story 2" is pending before the Kerala High Court
BJP leader and former MP Brijbhushan Sharan Singh has launched a scathing attack on Indian wrestl